UBS Initiates Coverage On Wave Life Sciences with Buy Rating, Announces Price Target of $11
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsInitiationPrice Target
UBS analyst Joon Lee initiates coverage on Wave Life Sciences (NASDAQ:WVE) with a Buy rating and announces Price Target of $11.
UBS analyst Joon Lee initiates coverage on Wave Life Sciences (NASDAQ:WVE) with a Buy rating and announces Price Target of $11.